Pablo Arturo Gaspar Ramos

Desde ORCID

• A Delphi Consensus Report on the Treatment of First Episode and Early-Phase Schizophrenia in Adolescents and Young Adults in Latin-America

  Corrales, A., Rebok, F., Cetkovich-Bakmas, M., Gaspar, P. A., Ng, B., Gargoloff, D., Vazquez, G., Vilapriño, J. J., Corral, R., Vilapriño, M., Gama, C., Lema Spinelli, S., Ramirez, J., Cordoba Rojas, R., Villaprado, J. M., Bressan, R., Gargoloff, P., Lamaison, F., Leiderman, E., Bustamante, C. E., Goldchluk, A., Andrada, D. & et al.

  doi:10.2139/ssrn.7266201

• Automatic Speech Recognition in Psychiatric Interviews: A Rocket to Diagnostic Support in Psychosis

  García Molina, J. T., Gaspar, P. A. & Figueroa-Barra, A.

  Revista Colombiana de Psiquiatría (English ed.), 54, 624-631 doi:10.1016/j.rcpeng.2025.11.013

• Clinical prediction model for transition to psychosis in individuals meeting At Risk Mental State criteria

  Bonnett, L. J., Hunt, A., Flores, A., Tudur Smith, C., Varese, F., Byrne, R., Law, H., Milicevic, M., Carney, R., Parker, S., Yung, A. R., On behalf of the IPPACT Study Group which also includes, Shah, J., Pruessner, M., Malla, A., Ziermans, T., Durston, S., Chang, W. C., Morrison, A., Shiers, D., van der Gaag, M., McFarlane, W. & et al.

  Schizophrenia, 11 doi:10.1038/s41537-025-00582-5

• Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample

  Allott, K., Yassin, W., Alameda, L., Billah, T., Borders, O., Buccilli, K., Carrión, R. E., Castillo-Passi, R. I., Cho, K. I. K., Chin, K., Coleman, M. J., Colton, B. L., Corral, S., Dwyer, D., Gundersen, K. B., Gur, R. C., Hoftman, G. D., Jacobs, G. R., Kelly, S., Lewandowski, K. E., Marcy, P. J., Matneja, P. & et al.

  Schizophrenia, 11 doi:10.1038/s41537-025-00578-1

• Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program

  Wigman, J. T. W., Ching, A. E., Chung, Y., Eichi, H. R., Lane, E., Langholm, C., Vaidyam, A., Byun, A. J. S., Haidar, A., Hartmann, J., Nunez, A., Dwyer, D., Nasarudin, A. A., Borders, O., Scott, I., Tamayo, Z., Matneja, P., Cho, K. I., Addington, J., Alameda, L. K., Arango, C., Breitborde, N. J. K. & et al.

  Schizophrenia, 11 doi:10.1038/s41537-025-00599-w

• Lifetime prevalence of psychotic-like experiences and associated factors in Chile

  González-Medina, G. A., Corral, S. A., Castillo-Passi, R. I., Irarrazaval, M., Maturana-Hurtado, A. J. & Gaspar, P. A.

  Social Psychiatry and Psychiatric Epidemiology, 60, 329-339 doi:10.1007/s00127-024-02741-y

• Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program

  Addington, J., Liu, L., Braun, A., Auther, A., Calkins, M. E., Cornblatt, B. A., Corcoran, C. M., Fusar-Poli, P., Kerr, M. J., Mourgues-Codern, C. V., Nunez, A. R., Oliver, D., Strauss, G. P., Walsh, B. C., Alameda, L. K., Arango, C., Breitborde, N. J. K., Broome, M. R., Cadenhead, K. S., Carrion, R. E., Chen, E. Y. H., Choi, J. & et al.

  Schizophrenia, 11 doi:10.1038/s41537-025-00556-7

• The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures

  Mathalon, D. H., Nicholas, S., Roach, B. J., Billah, T., Lavoie, S., Whitford, T., Hamilton, H. K., Addamo, L., Anohkin, A., Bekinschtein, T., Belger, A., Buccilli, K., Cahill, J., Carrión, R. E., Damiani, S., Dzafic, I., Ebdrup, B. H., Izyurov, I., Jarcho, J., Jenni, R., Jo, A., Kerins, S. & et al.

  Schizophrenia, 11 doi:10.1038/s41537-025-00622-0

• The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program

  Harms, M. P., Cho, K. I. K., Anticevic, A., Bolo, N. R., Bouix, S., Campbell, D., Cannon, T. D., Cecchi, G., Goncalves, M., Haidar, A., Hughes, D. E., Izyurov, I., John, O., Kapur, T., Kim, N., Kotler, E., Kubicki, M., Kuperman, J. M., Laulette, K., Lindberg, U., Markiewicz, C., Ning, L. & et al.

  Schizophrenia, 11 doi:10.1038/s41537-025-00581-6

• Women with polycystic ovary syndrome (PCOS): Likelihood of cooccurring neuropsychiatric conditions and the dual hit hypothesis

  Del Río, J. P., Tsompanidis, A., Gaspar, P. A., Maturana-Hurtado, A., Rojas-Costa, G. M., Dagnino-Subiabre, A., Olea, A., Maliqueo, M., Echiburú, B., de Guevara, A. L., Montiel, J. F., Baron-Cohen, S. & Crisosto, N.

  Frontiers in Neuroendocrinology, 77, 101188 doi:10.1016/j.yfrne.2025.101188

• Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

  Wannan, C. M. J., Nelson, B., Addington, J., Allott, K., Anticevic, A., Arango, C., Baker, J. T., Bearden, C. E., Billah, T., Bouix, S., Broome, M. R., Buccilli, K., Cadenhead, K. S., Calkins, M. E., Cannon, T. D., Cecci, G., Chen, E. Y. H., Cho, K. I. K., Choi, J., Clark, S. R., Coleman, M. J., Conus, P. & et al.

  Schizophrenia Bulletin, 50, 496-512 doi:10.1093/schbul/sbae011

• Development of the <scp>PSYCHS</scp> : Positive SYmptoms and Diagnostic Criteria for the <scp>CAARMS</scp> Harmonized with the <scp>SIPS</scp>

  Woods, S. W., Parker, S., Kerr, M. J., Walsh, B. C., Wijtenburg, S. A., Prunier, N., Nunez, A. R., Buccilli, K., Mourgues‐Codern, C., Brummitt, K., Kinney, K. S., Trankler, C., Szacilo, J., Colton, B., Ali, M., Haidar, A., Billah, T., Huynh, K., Ahmed, U., Adery, L. L., Marcy, P. J., Allott, K. & et al.

  Early Intervention in Psychiatry, 18, 255-272 doi:10.1111/eip.13457

• Disrupted third visual pathway function in schizophrenia: Evidence from real and implied motion processing

  Martínez, A., Gaspar, P. A., Bermudez, D. H., Belen Aburto-Ponce, M., Beggel, O. & Javitt, D. C.

  NeuroImage: Clinical, 41, 103570 doi:10.1016/j.nicl.2024.103570

• Fixational eye movements and their associated evoked potentials during natural vision are altered in schizophrenia

  Mayol-Troncoso, R., Gaspar, P. A., Verdugo, R., Mariman, J. J. & Maldonado, P. E.

  Schizophrenia Research: Cognition, 38, 100324 doi:10.1016/j.scog.2024.100324

• Hyperandrogenism and its Influence on Emotional and Social Development in Adolescent Daughters of Women with Polycystic Ovary Syndrome

  Journal of the Endocrine Society

• Imitative inhibitory control is associated with psychotic experiences in a sample from the general population

  Ulloa, J. L., Núñez, D. E., Gaspar, P. A. & Brass, M.

  Frontiers in Psychiatry, 15 doi:10.3389/fpsyt.2024.1470030

• Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive impairment in early stages of psychosis

  Corral, S., Gaspar, P. A., Castillo-Passi, R. I., Mayol Troncoso, R., Mundt, A. P., Ignatyev, Y., Nieto, R. R. & Figueroa-Muñoz, A.

  Schizophrenia Research: Cognition, 36, 100302 doi:10.1016/j.scog.2024.100302

• The impact of hormones on emotional and social development: a study in adolescent daughters of women with polycystic ovary syndrome

  European Psychiatry

• Bottom-up and top-down contributions to impaired motion processing in schizophrenia

  medRxiv

• Relation between cognitive impairments in alzheimer disease and depression

  IBRO Neuroscience Reports

• Automatic language analysis identifies and predicts schizophrenia in first-episode of psychosis

  Figueroa-Barra, A., Del Aguila, D., Cerda, M., Gaspar, P. A., Terissi, L. D., Durán, M. & Valderrama, C.

  Schizophrenia, 8 doi:10.1038/s41537-022-00259-3

• Disease-Specific Contribution of Pulvinar Dysfunction to Impaired Emotion Recognition in Schizophrenia

  Martínez, A., Tobe, R. H., Gaspar, P. A., Malinsky, D., Dias, E. C., Sehatpour, P., Lakatos, P., Patel, G. H., Bermudez, D. H., Silipo, G. & Javitt, D. C.

  Frontiers in Behavioral Neuroscience, 15 doi:10.3389/fnbeh.2021.787383

• Experiencia académica sobre la presentación de trabajos cient́ıficos en la IV Conferencia Internacional: Desaf́ıos cĺınicos y terapéuticos en psicosis

  Rev. chil. psiquiatr. neurol. infanc. adolesc.(Impr.)

• Las anomalías precoces de la continuidad en el discurso constituyen biomarcadores predictivos de psicosis

  Figueroa-Barra, A. I., León-Bustos, M. E. & Gaspar-Ramos, P.

  Rilce. Revista de Filología Hispánica, 1016-49 doi:10.15581/008.38.3.1016-49

• Análisis descriptivo de los trabajos cient́ıficos presentados en la segunda conferencia internacional Chilena de Psicosis 2020

  Rev. chil. psiquiatr. neurol. infanc. adolesc.(Impr.)

• BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review

  Nieto, R. R., Carrasco, A., Corral, S., Castillo, R., Gaspar, P. A., Bustamante, M. L. & Silva, H.

  Frontiers in Psychiatry, 12 doi:10.3389/fpsyt.2021.662407

• Intervención Temprana en Psicosis, una perspectiva cĺınica

• Examining the effect of a mindfulness based program for the improvement of cognitive function in an early stage of schizophrenia. A random controlled trial

  Langer, Á. I., Schmidt, C., Vergara, R., Mayol-Troncoso, R., Lecaros, J., Krogh, E., Vergara, C., Díaz, M., Rivera, G., Aguirre-Baez, R. & Gaspar, P. A.

  Schizophrenia Research, 223, 370-372 doi:10.1016/j.schres.2020.07.012

• Alteraciones de la cognición social en śındromes de alto riesgo en psicosis

  Revista chilena de neuro-psiquiatŕıa

• Alteraciones de la cognición social en síndromes de alto riesgo en psicosis

  Corral Z., S., Laborda, M., Miguez, G., Fernández, J., Saavedra, S., Zamora, D., Zegpi, C., Nieto, R., Silva, H. & Gaspar R., P. A.

  Revista chilena de neuro-psiquiatría, 57, 25-33 doi:10.4067/s0717-92272019000100025

• Convergent and Divergent Patterns of Atypical Visual Processing Underlying Face Emotion Recognition in Schizophrenia and ASD

  NEUROPSYCHOPHARMACOLOGY

• Early psychosis detection program in Chile: A first step for the South American challenge in psychosis research

  Gaspar, P. A., Castillo, R. I., Maturana, A., Villar, M. J., Ulloa, K., González, G., Ibaceta, O., Ortiz, A., Corral, S., Mayol, R., De Angel, V., Aburto, M. B., Martínez, A., Corcoran, C. M. & Silva, H.

  Early Intervention in Psychiatry, 13, 328-334 doi:10.1111/eip.12766

• EEG Resting-State Attentional Networks Abnormalities are Associated With Negative Symptoms and Cognitive Deficits in Ultra High-Risk Syndrome

  NEUROPSYCHOPHARMACOLOGY

• Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications

  Martínez, A., Gaspar, P. A., Hillyard, S. A., Andersen, S. K., Lopez-Calderon, J., Corcoran, C. M. & Javitt, D. C.

  American Journal of Psychiatry, 175, 1243-1254 doi:10.1176/appi.ajp.2018.18010072

• Cognitive impairment in agricultural workers and nearby residents exposed to pesticides in the Coquimbo Region of Chile

  Corral, S. A., de Angel, V., Salas, N., Zúñiga-Venegas, L., Gaspar, P. A. & Pancetti, F.

  Neurotoxicology and Teratology, 62, 13-19 doi:10.1016/j.ntt.2017.05.003

• Differential Deficits in Early Visual Processing Across Neuropsychiatric Populations: Implications for Screening and Intervention

  NEUROPSYCHOPHARMACOLOGY

• Shifting the focus toward rare variants in schizophrenia to close the gap from genotype to phenotype

  Bustamante, M. L., Herrera, L., Gaspar, P. A., Nieto, R., Maturana, A., Villar, M. J., Salinas, V. & Silva, H.

  American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 174, 663-670 doi:10.1002/ajmg.b.32550

• The effect of a mindfulness-based intervention in cognitive functions and psychological well-being applied as an early intervention in schizophrenia and high-risk mental state in a Chilean sample: study protocol for a randomized controlled trial

  Langer, Á. I., Schmidt, C., Mayol, R., Díaz, M., Lecaros, J., Krogh, E., Pardow, A., Vergara, C., Vergara, G., Pérez-Herrera, B., Villar, M. J., Maturana, A. & Gaspar, P. A.

  Trials, 18 doi:10.1186/s13063-017-1967-7

• Contribution of Impaired Motion Processing to Affect Recognition Deficits in Schizophrenia

  NEUROPSYCHOPHARMACOLOGY

• From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism

  Castillo, R. I., Rojo, L. E., Henriquez-Henriquez, M., Silva, H., Maturana, A., Villar, M. J., Fuentes, M. & Gaspar, P. A.

  Frontiers in Neuroscience, 10 doi:10.3389/fnins.2016.00488

• Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology

  Rojo, L. E., Gaspar, P. A., Silva, H., Risco, L., Arena, P., Cubillos-Robles, K. & Jara, B.

  Pharmacological Research, 101, 74-85 doi:10.1016/j.phrs.2015.07.022

• Neural oscillatory deficits in schizophrenia predict behavioral and neurocognitive impairments

  Martínez, A., Gaspar, P. A., Hillyard, S. A., Bickel, S., Lakatos, P., Dias, E. C. & Javitt, D. C.

  Frontiers in Human Neuroscience, 9 doi:10.3389/fnhum.2015.00371

• From Glutamatergic Dysfunction to Cognitive Impairment: Boundaries in the Therapeutic of the Schizophrenia

  A. Gaspar, P., L. Bustamante, M., E. Rojo, L. & Martinez, A.

  Current Pharmaceutical Biotechnology, 13, 1543-1548 doi:10.2174/138920112800784790

• A combined EEG-fMRI investigation of “rhythmic” versus “vigilant” processing I: neural dynamics

  Conference Abstract: XI International Conference on Cognitive Neuroscience (ICON XI). doi: 10.3389/conf. fnhum

• A combined EEG-fMRI investigation of “rhythmic” versus “vigilant” processing II: functional neuro-anatomy and slow dynamics

  Proceedings of the International Conference on Cognitive Neuroscience (ICON XI), Mallorca, Spain

• ALPHA FREQUENCY ALTERATIONS IN SCHIZOPHRENIA DURING HIGH WORKING MEMORY LOAD CONDITIONS

  SCHIZOPHRENIA BULLETIN

• Molecular Targets in the Rational Design of AD Specific PET Tracers: Tau or Amyloid Aggregates?

  E. Rojo, L., A. Gaspar, P. & B. Maccioni, R.

  Current Alzheimer Research, 8, 652-658 doi:10.2174/156720511796717203

• P300 amplitude is insensitive to working memory load in schizophrenia

  Gaspar, P. A., Ruiz, S., Zamorano, F., Altayó, M., Pérez, C., Bosman, C. A. & Aboitiz, F.

  BMC Psychiatry, 11 doi:10.1186/1471-244x-11-29

• Parametric increases of working memory load unveil a decreased alpha oscillatory activity in schizophrenia

  Gaspar, P. A., Bosman, C. A., Ruiz, S., Zamorano, F., Pérez, C. & Aboitiz, F.

  Schizophrenia Research, 131, 268-269 doi:10.1016/j.schres.2011.06.010

• PERCEPTUAL PRIMING: A STUDY OF CLOSURE PROCESSES IN SCHIZOPHRENIA

  SCHIZOPHRENIA BULLETIN

• Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications

  Gaspar, P. A., Bustamante, M. L., Silva, H. & Aboitiz, F.

  Journal of Neurochemistry, 111, 891-900 doi:10.1111/j.1471-4159.2009.06325.x

• The aberrant connectivity hypothesis in schizophrenia

  From Attention to Goal Directed Behavior Neurodynamical Methodological and Clinical Trendsenlace

• Integración neuronal de memoria de trabajo a través de la actividad oscilatoria sincrónica en sujetos sanos y en pacientes esquizofrénicos

  Rev. psiquiatr. cĺın.(Santiago de Chile)